Katherine Wei

Overview

Katherine brings one of the most academically elite profiles in the entire MAP ecosystem — a 5.0 GPA at MIT, dual-track Biological Engineering & Finance, and research commitments with both the Koch Institute and MIT Laboratory for Financial Engineering. She blends hard science, valuation thinking, and institutional exposure through Global Platinum Securities, where she is one of four selected analysts in her class and already pitching NASDAQ/NYSE names. Katherine is polished, curious, and intellectually rigorous — a returning MAP fellow who consistently demonstrates maturity far beyond class stage. A top-tier candidate with analyst-level drive, technical learning agility, and long-term front-office potential.

Strengths

• MIT 5.0 academic record — top percentile quantitative horsepower.
• Investment fund experience at GPS with healthcare sector coverage and live pitch responsibility.
• Institutional research pedigree — cancer immunotherapy + finance research under leading MIT faculty.
• Leadership depth — club recruitment, lab execution, rowing discipline, and national competition exposure.

Areas for Development

• As finance experience deepens, increasing IB-style modeling reps will unlock analyst polish quickly.
• Opportunity to convert scientific analytical style into investor-facing synthesis and storytelling.
• High ceiling — compounding reps translate to genuine front-office potential.

Projection

Katherine projects as a future standout analyst — technically capable, research-proven, and driven to learn rapidly. With her cross-training in biotech and finance, she fits exceptionally well into healthcare-focused IB, growth equity, or later-stage venture. One of the most academically impressive prospects in this class, with an upward trajectory that suggests long-term leadership potential in the finance and life sciences deal ecosystem.